Market Overview

Morgan Stanley Offers Pre-2Q Thoughts on Monsanto Company

Share:
Related MON
Top 4 NYSE Stocks In The Agricultural Chemicals Industry With The Highest ROI
Monsanto Slightly Maintaining Gains Following Better-Than-Expected Earnings
Syngenta Encounters Margin Loss Woes, Scopes Exist - Analyst Blog (Zacks)

In a report published Thursday, Morgan Stanley analyst Vincent Andrews reiterated an Overweight rating and $150.00 price target on Monsanto Company (NYSE: MON).

In the report, Morgan Stanley noted, “F2Q buy side expectations appear below consensus but largely inline with our own due to a weather timing shift into F3Q. A modest bump to both the low and the high end of guidance is likely, but we do not anticipate a material guidance upgrade until F3Q reporting when all of the seed is planted.”

Monsanto Company closed on Wednesday at $111.72.

Latest Ratings for MON

DateFirmActionFromTo
Jan 2015CitigroupMaintainsBuy
Jan 2015Deutsche BankMaintainsBuy
Jan 2015JP MorganMaintainsOverweight

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Vincent AndrewsAnalyst Color Reiteration Analyst Ratings

 

Related Articles (MON)

Around the Web, We're Loving...

Get Benzinga's Newsletters